Zeev Estrov

Department of Leukemia, The University of Texas MD Anderson Cancer Center

Affiliated withThe University of Texas MD Anderson Cancer Center

Research Area

Biography

Zeev Estrov has not added Biography.
If you are Zeev Estrov and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2016

Other Publications

Article	Year
Shift of immunoglobulin phenotypes in B-cell precursor cell lines. Leukemia research\| PubMed ID: 11734298	2002
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood\| PubMed ID: 11756188	2002
Cellular signalling pathways: new targets in leukaemia therapy. British journal of haematology\| PubMed ID: 11841398	2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. The New England journal of medicine\| PubMed ID: 11882729	2002
Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors. Journal of clinical apheresis\| PubMed ID: 11948700	2002
Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia. Blood\| PubMed ID: 11964319	2002
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leukemia research\| PubMed ID: 12007503	2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leukemia research\| PubMed ID: 12008081	2002
Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission. British journal of haematology\| PubMed ID: 12060122	2002
Reduced focal adhesion kinase and paxillin phosphorylation in BCR-ABL-transfected cells. Cancer\| PubMed ID: 12124845	2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood\| PubMed ID: 12149200	2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia. Cancer chemotherapy and pharmacology\| PubMed ID: 12497210	2003
N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Leukemia research\| PubMed ID: 12537979	2003
Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12576416	2003
Commentary: effect of flavonoids on normal and leukemic cells. Leukemia research\| PubMed ID: 12648504	2003
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood\| PubMed ID: 12663443	2003
Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid l... Blood\| PubMed ID: 12689943	2003
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome. Blood\| PubMed ID: 12730116	2003
Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor. Blood\| PubMed ID: 12881315	2003
Adult stem cells for tissue repair - a new therapeutic concept? The New England journal of medicine\| PubMed ID: 12904523	2003
Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14506164	2003
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation\| PubMed ID: 14568894	2003
Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia. Human pathology\| PubMed ID: 14991544	2004
Hematopoietic recovery following induction therapy of acute leukemias: prognostic implications and a new look at the definition of remission. Leukemia & lymphoma\| PubMed ID: 15061199	2004
Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood\| PubMed ID: 15070700	2004
Arsenic derivatives as therapeutic agents for hematologic malignancies. Leukemia research\| PubMed ID: 15234564	2004
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood\| PubMed ID: 15486072	2005
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Cancer research\| PubMed ID: 15520199	2004
Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination. Genes, chromosomes & cancer\| PubMed ID: 15543623	2005
Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation\| PubMed ID: 15596566	2004
Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. Hematology (Amsterdam, Netherlands)\| PubMed ID: 15621735	2004
Metastasis--an alternative hypothesis. Cancer\| PubMed ID: 15739196	2005
A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute... Cancer research\| PubMed ID: 15805291	2005
AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells. Cancer\| PubMed ID: 16078266	2005
Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. Journal of vascular research\| PubMed ID: 16088214	2005
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML). Anticancer research\| PubMed ID: 16158916	2005
Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma. Leukemia research\| PubMed ID: 16203034	2006
Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance. Blood\| PubMed ID: 16291594	2006
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood\| PubMed ID: 16293603	2006
The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leukemia research\| PubMed ID: 16332390	2006
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action. Journal of the National Cancer Institute\| PubMed ID: 16333034	2005
Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older. Blood\| PubMed ID: 16403905	2006
Eradication of leukemia stem cells as a new goal of therapy in leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16428470	2006
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia. Blood\| PubMed ID: 16551975	2006
Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood\| PubMed ID: 16556893	2006
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia. Cancer research\| PubMed ID: 16585200	2006
Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cells. Leukemia research\| PubMed ID: 16828865	2007
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood\| PubMed ID: 16882708	2007
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood\| PubMed ID: 16882711	2006
Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: implications for imatinib mesylate response and resistance. Leukemia & lymphoma\| PubMed ID: 16966279	2006
重组人粒细胞-集落刺激因子动员和机采收集的内皮祖&#x7E... Transfusion\| PubMed ID: 17002637	2006
Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thrombosis and haemostasis\| PubMed ID: 17003929	2006
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome. Leukemia & lymphoma\| PubMed ID: 17071475	2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer cell\| PubMed ID: 17097560	2006
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy. Cancer\| PubMed ID: 17154172	2007
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study. Blood\| PubMed ID: 17158228	2007
Studying the right cell in acute myelogenous leukemia: dynamic changes of apoptosis and signal transduction pathway protein expression in chemotherapy resistant ex-vivo selected "survivor ce... Cell cycle (Georgetown, Tex.)\| PubMed ID: 17172852	2006
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells. Blood\| PubMed ID: 17202319	2007
Biphenotypic acute leukaemia: a case series. British journal of haematology\| PubMed ID: 17593028	2007
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome. Blood\| PubMed ID: 17596541	2007
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer research\| PubMed ID: 18056455	2007
Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18182662	2008
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 18224667	2008
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. Journal of the National Cancer Institute\| PubMed ID: 18230792	2008
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18245540	2008
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood\| PubMed ID: 18334676	2008
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Molecular cancer therapeutics\| PubMed ID: 18347134	2008
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax). Cancer research\| PubMed ID: 18451169	2008
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies. Cancer\| PubMed ID: 18473351	2008
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Cancer science\| PubMed ID: 18482053	2008
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia. Blood\| PubMed ID: 18495956	2008
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodyspla... Blood\| PubMed ID: 18565853	2008
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leukemia research\| PubMed ID: 18715642	2009
Clofarabine combinations as acute myeloid leukemia salvage therapy. Cancer\| PubMed ID: 18756533	2008
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19075265	2009
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience. International journal of hematology\| PubMed ID: 19340529	2009
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer research\| PubMed ID: 19383925	2009
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndr... Journal of hematology & oncology\| PubMed ID: 19439093	2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19458051	2009
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia. Leukemia research\| PubMed ID: 19679351	2010
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation. International journal of hematology\| PubMed ID: 19728024	2009
The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up. Blood\| PubMed ID: 19729517	2009
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug re... Blood\| PubMed ID: 19762485	2009
Stem cells and somatic cells: reprogramming and plasticity. Clinical lymphoma & myeloma\| PubMed ID: 19778860	2009
Clinical correlation of circulating heat shock protein 70 in acute leukemia. Leukemia research\| PubMed ID: 19800118	2010
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19826111	2009
Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Blood\| PubMed ID: 20008298	2010
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood\| PubMed ID: 20154216	2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20212254	2010
The leukemia stem cell. Cancer treatment and research\| PubMed ID: 20306242	2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leukemia research\| PubMed ID: 20362333	2010
Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor. Investigational new drugs\| PubMed ID: 20372971	2011
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20421540	2010
Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC. Blood\| PubMed ID: 20479284	2010
Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics\| PubMed ID: 20484983	2010
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy. Cancer\| PubMed ID: 20499401	2010
Kit inhibitor APcK110 extends survival in an AML xenograft mouse model. Investigational new drugs\| PubMed ID: 20517635	2011
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells. Investigational new drugs\| PubMed ID: 20533075	2011
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood\| PubMed ID: 20679526	2010
Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PloS one\| PubMed ID: 20686606	2010
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. The New England journal of medicine\| PubMed ID: 20843246	2010
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance. Leukemia research\| PubMed ID: 20951430	2011
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplast... Cancer\| PubMed ID: 20960519	2011
STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells. Molecular cancer research : MCR\| PubMed ID: 21364020	2011
Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB01842... Cancer\| PubMed ID: 21480207	2011
Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor. Cancer research\| PubMed ID: 21512135	2011
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21555694	2011
Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PloS one\| PubMed ID: 21731684	2011
Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3. Human pathology\| PubMed ID: 21733558	2011
Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia. Blood\| PubMed ID: 21750315	2011
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome. Cancer\| PubMed ID: 21751197	2012
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 21858802	2011
Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood\| PubMed ID: 21868570	2011
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome. American journal of hematology\| PubMed ID: 22072492	2012
Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leukemia & lymphoma\| PubMed ID: 22303899	2012
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodys... British journal of haematology\| PubMed ID: 22360602	2012
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia. Blood\| PubMed ID: 22422826	2012
Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis. Leukemia research\| PubMed ID: 22475363	2012
Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 22578814	2012
A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 22579233	2012
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls. Blood\| PubMed ID: 22718840	2012
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature\| PubMed ID: 22820254	2012
Ocular granulocytic sarcoma: a case report and literature review of ocular extramedullary acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23017332	2013
Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly. Blood\| PubMed ID: 23019204	2012
Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23246163	2013
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice. PloS one\| PubMed ID: 23251462	2012
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23265768	2013
The significance of spliceosome mutations in chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 23270583	2013
Is acute myeloid leukemia a liquid tumor? International journal of cancer\| PubMed ID: 23280377	2013
Central nervous system Richter's transformation and parvovirus B19 infection. Leukemia & lymphoma\| PubMed ID: 23320889	2013
Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease? Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23332395	2013
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis. Leukemia & lymphoma\| PubMed ID: 23343175	2013
Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein-Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 23387894	2013
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome. American journal of hematology\| PubMed ID: 23512829	2013
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD. British journal of haematology\| PubMed ID: 23530930	2013
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Molecular cancer\| PubMed ID: 23725032	2013
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23733767	2013
Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia. PloS one\| PubMed ID: 23750211	2013
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia. American journal of hematology\| PubMed ID: 23760779	2013
Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a. Blood\| PubMed ID: 23782935	2013
CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23800602	2013
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood\| PubMed ID: 23821659	2013
Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile. Leukemia & lymphoma\| PubMed ID: 23829280	2014
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood\| PubMed ID: 23836561	2013
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia. American journal of hematology\| PubMed ID: 23877926	2013
Personalized medicine in CLL: current status and future perspectives. Cancer letters\| PubMed ID: 23879961	2014
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PloS one\| PubMed ID: 23936456	2013
Targeting inflammatory pathways in chronic lymphocytic leukemia. Critical reviews in oncology/hematology\| PubMed ID: 23941728	2013
Interaction between myelomonocytic and lymphoid cells in a patient with acute myelomonocytic leukemia and chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 23987820	2014
Detection of dormant chronic myeloid leukemia clones in the bone marrow of patients in complete molecular remission. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 24060288	2013
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells. PloS one\| PubMed ID: 24376763	2013
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia. Blood\| PubMed ID: 24578497	2014
Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood\| PubMed ID: 24615780	2014
Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia. Cancer medicine\| PubMed ID: 24678068	2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL. Blood\| PubMed ID: 24705492	2014
Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations. Cancer\| PubMed ID: 24737502	2014
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells. Blood\| PubMed ID: 24778152	2014
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis. Molecular cancer research : MCR\| PubMed ID: 24836891	2014
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 24875590	2014
Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 24982452	2016
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia. Cancer\| PubMed ID: 25043749	2014
Myeloid neoplasms after breast cancer: "therapy-related" not an independent poor prognostic factor. Leukemia & lymphoma\| PubMed ID: 25048874	2015
Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 25110819	2015
Isolated mesenteric CD20-positive myeloid sarcoma. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 25131853	2014
Clinical significance of microcytosis in patients with primary myelofibrosis. Leukemia research\| PubMed ID: 25217891	2014
Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25238756	2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leukemia & lymphoma\| PubMed ID: 25308294	2015
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia. American journal of hematology\| PubMed ID: 25368968	2015
Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia. British journal of haematology\| PubMed ID: 25413673	2015
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome. American journal of hematology\| PubMed ID: 25530214	2015
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood\| PubMed ID: 25573991	2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome. American journal of hematology\| PubMed ID: 25683856	2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells. Molecular cancer research : MCR\| PubMed ID: 25733697	2015
Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome. American journal of hematology\| PubMed ID: 25808231	2015
The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide mo... British journal of haematology\| PubMed ID: 25824652	2015
Meir Wetzler, MD. Cancer\| PubMed ID: 25832851	2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 25847930	2015
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia. American journal of hematology\| PubMed ID: 25850565	2015
Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera - single center experience. Leukemia & lymphoma\| PubMed ID: 25904378	2016
Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome. Leukemia research\| PubMed ID: 26012362	2015
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens. Cancer\| PubMed ID: 26193999	2015
Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia. Cancer\| PubMed ID: 26218678	2015
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine\| PubMed ID: 26288818	2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer\| PubMed ID: 26308885	2015
Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation. Cancer genetics\| PubMed ID: 26382622	2015
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics. Leukemia & lymphoma\| PubMed ID: 26402369	2016
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. The Lancet. Oncology\| PubMed ID: 26432046	2015
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. American journal of hematology\| PubMed ID: 26437693	2016
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia. British journal of haematology\| PubMed ID: 26492205	2016
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia. Cancer\| PubMed ID: 26588193	2016
Metabolism pathways in chronic lymphocytic leukemia. Leukemia & lymphoma\| PubMed ID: 26643954	2016
DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 26700872	2015
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood\| PubMed ID: 26729897	2016
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 26752456	2016
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. American journal of hematology\| PubMed ID: 26799924	2016
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents. Oncotarget\| PubMed ID: 26871476	2016
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica\| PubMed ID: 27013651	2016
At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27076684	2016